These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18184289)

  • 1. Intrapatient variability of migraine attacks: stability analysis of the MIGSEV scale.
    Baha M; Nachit-Ouinekh F; El Hasnaoui A
    Headache; 2008 Jan; 48(1):79-85. PubMed ID: 18184289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of migraine severity using the MIGSEV scale: relationship to migraine features and quality of life.
    El Hasnaoui A; Vray M; Blin P; Nachit-Ouinekh F; Boureau F;
    Cephalalgia; 2004 Apr; 24(4):262-70. PubMed ID: 15030534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of migraine on patients and their families: the Migraine And Zolmitriptan Evaluation (MAZE) survey--Phase III.
    MacGregor EA; Brandes J; Eikermann A; Giammarco R
    Curr Med Res Opin; 2004 Jul; 20(7):1143-50. PubMed ID: 15265259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can migraineurs accurately identify their headaches as "migraine" at attack onset?
    Ng-Mak DS; Cady R; Chen YT; Ma L; Bell CF; Hu XH
    Headache; 2007 May; 47(5):645-53. PubMed ID: 17501845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of disease features on adherence to prophylactic migraine medication.
    Linde M; Jonsson P; Hedenrud T
    Acta Neurol Scand; 2008 Dec; 118(6):367-72. PubMed ID: 18513346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The course of frequent episodic migraine in a large headache clinic population: a 12-year retrospective follow-up study.
    Dahlöf CG; Johansson M; Casserstedt S; Motallebzadeh T
    Headache; 2009 Sep; 49(8):1144-52. PubMed ID: 19719542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The occipital alpha rhythm related to the "migraine cycle" and headache burden: a blinded, controlled longitudinal study.
    Bjørk MH; Stovner LJ; Nilsen BM; Stjern M; Hagen K; Sand T
    Clin Neurophysiol; 2009 Mar; 120(3):464-71. PubMed ID: 19157973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 'Act when Mild' (AwM) study: a step forward in our understanding of early treatment in acute migraine.
    Goadsby PJ
    Cephalalgia; 2008 Sep; 28 Suppl 2():36-41. PubMed ID: 18715331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migraine: a better way to recognize and treat it.
    Landy SH; Kwong WJ; Hutchinson S; Roselli A; Burch SP
    J Fam Pract; 2006 Dec; 55(12):1038-47. PubMed ID: 17137539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nebivolol and metoprolol for treating migraine: an advance on beta-blocker treatment?
    Schellenberg R; Lichtenthal A; Wöhling H; Graf C; Brixius K
    Headache; 2008 Jan; 48(1):118-25. PubMed ID: 18184294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How well do headache patients remember? A comparison of self-report measures of headache frequency and severity in patients with migraine.
    McKenzie JA; Cutrer FM
    Headache; 2009 May; 49(5):669-72. PubMed ID: 19456879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Migraine: a review and future directions for treatment.
    Linde M
    Acta Neurol Scand; 2006 Aug; 114(2):71-83. PubMed ID: 16867028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 24-hour distribution of migraine attacks.
    Alstadhaug K; Salvesen R; Bekkelund S
    Headache; 2008 Jan; 48(1):95-100. PubMed ID: 18184291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of attack frequency in migraine treatment.
    Maas HJ; Snelder N; Danhof M; Della Pasqua O
    Cephalalgia; 2008 Aug; 28(8):847-55. PubMed ID: 18540870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A pivotal moment in 50 years of headache history: the first American Migraine Study.
    Tepper SJ
    Headache; 2008 May; 48(5):730-1; discussion 732. PubMed ID: 18471125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early vs. non-early intervention in acute migraine-'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan.
    Goadsby PJ; Zanchin G; Geraud G; de Klippel N; Diaz-Insa S; Gobel H; Cunha L; Ivanoff N; Falques M; Fortea J
    Cephalalgia; 2008 Apr; 28(4):383-91. PubMed ID: 18294251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of transcatheter patent foramen ovale closure in migraineurs with moderate to large right-to-left shunt and instrumental evidence of cerebrovascular damage.
    Papa M; Gaspardone A; Fragasso G; Ajello S; Gioffrè G; Iamele M; Iani C; Margonato A
    Am J Cardiol; 2009 Aug; 104(3):434-9. PubMed ID: 19616680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Depression and quality of life in patients with glaucoma: a cross-sectional analysis using the Geriatric Depression Scale-15, assessment of function related to vision, and the Glaucoma Quality of Life-15.
    Skalicky S; Goldberg I
    J Glaucoma; 2008; 17(7):546-51. PubMed ID: 18854731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The correlation between nasal symptom and mucociliary clearance in allergic rhinitis.
    Kirtsreesakul V; Somjareonwattana P; Ruttanaphol S
    Laryngoscope; 2009 Aug; 119(8):1458-62. PubMed ID: 19507239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
    Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
    Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.